Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > ETNB jumos on phase 2 b Nash results
View:
Comment by palinc2000 on Mar 22, 2023 8:24am
Over 250 million $ increase in market cap on this news  
Comment by Trogarzon on Mar 22, 2023 8:43am
Infuriating to see our P2/3 Nash program worth 0, ZERO, NADA, LING... 
Comment by scarlet1967 on Mar 22, 2023 8:50am
Phase 2 NASH company and that's mostly all this company is about, market cap $570m, as of December 2022 had $188m cash if they hold the gain 3/4 billion valuation or over half a billion excluding the cash! https://www.89bio.com/pipeline/  
Comment by Trogarzon on Mar 22, 2023 9:06am
All that to say that our Allstar management has never been able to CREATE any value out of this expensive pipeline.  What do I care for the 20 tons worth of papers and studies if it account for ZERO now... no sorry -50M, the dept they incured for that big ZERO. It's a complete joke to have a P2/3 ready to go program backed by Greenspoon and Loomba that is worth ZERO.  Unless it's ...more  
Comment by Trogarzon on Mar 22, 2023 9:41am
Now that just oulined a good question for those guys, WHY is our Nash P.2// program worth NOTHING when all those P1s, P2s ARE... WHY.
Comment by Trogarzon on Mar 22, 2023 9:50am
Could it be... just suggesting that the communication or the marketing of the story has been deficient.  They don't seem to even consider this fact but could it be a factor that they keep ignoring and that has a price for shareholders.  A price of 80 cents.
Comment by palinc2000 on Mar 22, 2023 10:06am
I know I can be redundant but the root cause of the low valuation is the terrible terrible decision 5 years ago to do a 55 Million $ Convert instead of issuing stock at 11 US  per share .The chickens are coming home to roost !!! Take away the substantial cash on hand at Entb and the market cap (ex cash) would not be anywhere close to 500 million... Cash in a Biotech is akin to blood in our ...more  
Comment by realitycheck4u on Mar 22, 2023 10:23am
This post has been removed in accordance with Community Policy
Comment by Trogarzon on Mar 22, 2023 12:08pm
Start over again.. don't anyone here have enough of this... SELL the company to the highest bidder.  Don't tell me to sell my shares on the market... I can't not liquid.  Stop it please and sell.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities